• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗癌症研究所中CYP17 MspA1基因多态性与不同发病年龄乳腺癌患者的关系

CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran.

作者信息

Ebrahimi Elmira, Sabokbar Tayebeh, Eskandarieh Sharareh, Peyghambari Vahideh, Shirkoohi Reza

机构信息

Group of Genetics, Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Neurology & Neurosciences Research Center, Qom University of Medical Sciences, Qom, Iran.

出版信息

Iran J Public Health. 2017 Apr;46(4):537-544.

PMID:28540271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5439044/
Abstract

BACKGROUND

Exposure to endogenous hormones such as estrogen is known as a lifetime Breast Cancer (BC) risk factor. Polymorphisms in genes that are involved in the steroidogenic process, such as Cytochrome P450c17alpha (, affect individuals' susceptibility to BC. In Iran, the highest incident of BC is among young women. This study aimed to find prevalence of Single Nucleotide Polymorphisms (SNPs) in genes such as and significant correlation with age-oriented group of breast cancer.

METHODS

In 2016, a case series study was conducted on a total population of 205 patients suffering from breast cancer referred to Cancer Institute, Imam Khomeini Hospital Complex, Tehran, Iran. This population consisted of 104 cases less than 40 yr old and 101 cases over 40. The genotype variants of were determined using PCR, followed by RFLP. The association of polymorphisms with the risk of BC in two different age groups was evaluated by calculating odds ratio and 95% confidence intervals using unconditional logistic regression.

RESULTS

Carriers of at least one A2 allele may have higher risk of developing breast cancer at younger age compared to patients with A1/A1 genotype (Odds Ratio: 1.99, 95% Confidence Interval: 1.11-3.57, 0.02).

CONCLUSION

gene polymorphisms may have influence on the early onset of breast cancer.

摘要

背景

接触内源性激素如雌激素被认为是乳腺癌(BC)的终生风险因素。参与类固醇生成过程的基因多态性,如细胞色素P450c17α(),影响个体对乳腺癌的易感性。在伊朗,乳腺癌发病率最高的是年轻女性。本研究旨在发现基因如中的单核苷酸多态性(SNP)的患病率以及与不同年龄组乳腺癌的显著相关性。

方法

2016年,对转诊至伊朗德黑兰伊玛目霍梅尼医院综合癌症研究所的205例乳腺癌患者进行了病例系列研究。该人群包括104例年龄小于40岁的病例和101例年龄大于40岁的病例。使用聚合酶链反应(PCR),随后进行限制性片段长度多态性分析(RFLP)来确定的基因型变体。通过使用无条件逻辑回归计算比值比和95%置信区间,评估两个不同年龄组中多态性与乳腺癌风险的关联。

结果

与A1/A1基因型患者相比,至少携带一个A2等位基因的携带者在年轻时患乳腺癌的风险可能更高(比值比:1.99,95%置信区间:1.11 - 3.57,P = 0.02)。

结论

基因多态性可能对乳腺癌的早期发病有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/345c/5439044/d548c0182fe2/IJPH-46-537-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/345c/5439044/d548c0182fe2/IJPH-46-537-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/345c/5439044/d548c0182fe2/IJPH-46-537-g001.jpg

相似文献

1
CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran.伊朗癌症研究所中CYP17 MspA1基因多态性与不同发病年龄乳腺癌患者的关系
Iran J Public Health. 2017 Apr;46(4):537-544.
2
CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.在一项基于德国人群的病例对照研究中,CYP17 5'-非翻译区MspA1多态性与绝经前乳腺癌风险
Breast Cancer Res. 2005;7(4):R455-64. doi: 10.1186/bcr1027. Epub 2005 Apr 12.
3
The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.细胞色素P450 17α-羟化酶/17,20-裂解酶(CYP17)MspA1多态性与乳腺癌风险:一项荟萃分析。
Mutagenesis. 2002 Mar;17(2):119-26. doi: 10.1093/mutage/17.2.119.
4
Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.一种具有基因剂量效应的CYP17基因多态性与前列腺癌和良性前列腺增生风险增加相关。
Cancer Res. 2000 Oct 15;60(20):5710-3.
5
Genetic polymorphism of CYP17 and breast cancer risk in Korean women.韩国女性中CYP17基因多态性与乳腺癌风险
Exp Mol Med. 2005 Feb 28;37(1):11-7. doi: 10.1038/emm.2005.2.
6
CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.CYP17 MspA1基因多态性与胆道癌和胆结石风险:基于中国上海人群的研究
Int J Cancer. 2006 Jun 1;118(11):2847-53. doi: 10.1002/ijc.21708.
7
Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.CYP17 Mspa1 多态性与前列腺癌风险之间缺乏关联:14494 例病例和 15971 例对照的荟萃分析。
Medicina (Kaunas). 2013;49(2):51-5.
8
CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.CYP17(T-34C)和 CYP19(Trp39Arg)多态性及其对乳腺癌易感性的协同作用。
In Vivo. 2010 Jan-Feb;24(1):71-4.
9
Association of Cytochrome-17 (MspA1) Gene Polymorphism with Risk of Gall Bladder Stones and Cancer in North India.
Asian Pac J Cancer Prev. 2015;16(13):5557-63. doi: 10.7314/apjcp.2015.16.13.5557.
10
Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.雌激素代谢基因CYP17、CYP1A1和COMT的基因型多态性与乳腺癌风险:一项关于癌症易感性的多基因研究。
Cancer Res. 1999 Oct 1;59(19):4870-5.

引用本文的文献

1
Genetic and molecular biology of breast cancer among Iranian patients.伊朗患者乳腺癌的遗传和分子生物学。
J Transl Med. 2019 Jul 8;17(1):218. doi: 10.1186/s12967-019-1968-2.

本文引用的文献

1
Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.细胞色素P450基因在乳腺癌病因学及治疗中的作用:对雌激素生物合成、代谢及内分泌治疗反应的影响
Cancer Causes Control. 2015 Mar;26(3):319-32. doi: 10.1007/s10552-014-0519-7. Epub 2015 Jan 3.
2
The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1).细胞色素P450 17A1(P450c17,CYP17A1)的多样化学性质。
J Steroid Biochem Mol Biol. 2015 Jul;151:52-65. doi: 10.1016/j.jsbmb.2014.11.026. Epub 2014 Dec 4.
3
CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users.
细胞色素P450 17α-羟化酶/17,20-裂解酶多态性(rs743572)与吸烟人群患胆囊癌风险增加有关。
Tumour Biol. 2014 Jul;35(7):6531-7. doi: 10.1007/s13277-014-1876-2. Epub 2014 Apr 1.
4
MspA1 polymorphism of the CYP17 gene in breast cysts.CYP17 基因 MspA1 多态性与乳腺囊肿。
Gynecol Endocrinol. 2012 Jun;28(6):443-6. doi: 10.3109/09513590.2011.614115. Epub 2012 Mar 29.
5
Genetics of age at menarche: a systematic review.月经初潮年龄的遗传学研究:系统综述。
Hum Reprod Update. 2012 Mar-Apr;18(2):198-210. doi: 10.1093/humupd/dmr050. Epub 2012 Jan 18.
6
Breast cancer screening among females in Iran and recommendations for improved practice: a review.伊朗女性乳腺癌筛查及改进措施建议:一项综述
Asian Pac J Cancer Prev. 2011;12(7):1647-55.
7
Twenty years of breast cancer in Iran: downstaging without a formal screening program.伊朗二十年乳腺癌观察:降期而无正规筛查项目
Ann Oncol. 2011 Jan;22(1):93-97. doi: 10.1093/annonc/mdq303. Epub 2010 Jun 9.
8
CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.CYP17(T-34C)和 CYP19(Trp39Arg)多态性及其对乳腺癌易感性的协同作用。
In Vivo. 2010 Jan-Feb;24(1):71-4.
9
Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.CYP17 MspA1 多态性与乳腺癌风险之间缺乏关联:22090 例病例和 28498 例对照的荟萃分析。
Breast Cancer Res Treat. 2010 Jul;122(1):259-65. doi: 10.1007/s10549-009-0695-4. Epub 2009 Dec 24.
10
No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects.CYP17 T-34C 多态性与乳腺癌风险之间无关联:一项涉及 58814 例受试者的荟萃分析。
Breast Cancer Res Treat. 2010 Jul;122(1):221-7. doi: 10.1007/s10549-009-0679-4. Epub 2009 Dec 15.